why choose us

300×250 Ad Slot

Research Article: Pentapeptide cRGDfK-Surface Engineered Nanostructured Lipid Carriers as an Efficient Tool for Targeted Delivery of Tyrosine Kinase Inhibitor for Battling Hepatocellular Carcinoma

Date Published: 2023-11-28

Abstract:
Graphical Abstract:

Introduction:
The worldwide prevalence of liver cancer continues to rise, posing a global health problem. By , it is anticipated that yearly incidences of liver cancer will exceed million. By , liver cancer is projected by the World Health Organization to cause the deaths of over . million individuals. Hepatocellular carcinoma (HCC) is the primary subtype of liver cancer, constituting % of cases.

Read more

300×250 Ad Slot